Journal of Applied Physiology, 64 (1), 115-119
In Wegovys trials, all participants had excess body weight or obesity
As the medical literature matures around this topic, intermittent fasting may become a well-supported option for weight management
Results showed that if all participants adhered to treatment, semaglutide 7.2mg achieved a superior weight loss of 20.7 per cent versus 2.4 per cent with placebo after 72 weeks, with a third of participants losing 25 per cent or more of their body wright compared to placebo, it added
Moreover, the association between stressful life events and MS exacerbations suggests a complex interplay between stress, neuroinflammation, and disease progression in MS
The targeted neurological applications of NAC and glycine are increasingly supported by advanced, high-resolution imaging studies